DRC is accredited for phase I., II. studies by National Pharmaceutical Institute.

DRC provides comprehensive research and accelerated development services for pharmaceutical products according to ICH-GCP and FDA standards. 		 


ˇ Phase I Trials

DRC has an independent Phase 1 Unit, with a total capacity of 18 beds. Short and long term hospitalization is possible.

Rooms, bathrooms and toilets are equipped with an Internal alarm system.

The nearby Intensive Care Unit, the recreation room, the separate drug supply unit and the Archive room all serve the Site.

DRC performs the following types of clinical trials: first-into-man; interaction; pharmacokinetics for patients with liver and kidney diseases; bioequivalence and bioavailability

The attached reference list demonstrates the international acceptance of DRC’s Phase I activities.